评论文章:了解微生物组在乳腺癌进展中的作用
Seema Kumari1, Mundla Srilatha2, Ganji Purnachndra Nagaraju3
1Department of Biotechnology, Dr. B.R Ambedkar University, Srikakulam 532410, Andhra Pradesh, India.
Critical reviews in oncogenesis
|June 25, 2025
概括
肠道和乳腺微生物组失调影响乳腺癌的发展和转移. 针对微生物组的治疗策略,包括益生菌和免疫疗法,有望改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 乳腺癌的死亡率是一个全球性的健康问题.
- 微生物组失调影响乳腺癌的发病,转移,免疫反应和激素代谢.
- 代谢变化,如27-基胆固醇促进他莫西芬耐药性,与癌症的发展有关.
研究的目的:
- 讨论肠道和乳腺微生物组在乳腺癌中的作用.
- 探索针对乳腺癌的微生物向治疗方法.
- 突出涉及微生物组-免疫系统-外体组相互作用的新兴治疗方法.
主要方法:
- 对乳腺癌,微生物组和治疗策略的当前文献的综述.
- 分析微生物形状对恶性组织的影响.
- 检查受微生物群影响的代谢途径.
主要成果:
- 与健康组织相比,恶性乳腺组织表现出不同的微生物特征.
- 微生物化合物 (例如β-glucuronidases,SCFAs) 影响新陈代谢,耐药性和癌症进展.
- 失生症与雌激素受体阳性 (ER+) 乳腺癌中塔莫西芬耐药性有关.
结论:
- 准微生物组为乳腺癌提供了替代治疗策略.
- 像免疫疗法和纳米粒子输送系统这样的新兴方法显示出潜力.
- 了解微生物组与宿主相互作用是提高治疗疗效和降低耐药性的关键.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


